Pancreatic Cancer Research

ResearcherAffiliated Hospital of Nantong UniversityNo recent work listed

Yong Kwon Han

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9935-2978; OpenAlex author ID A5029453738. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2014: 1 paper · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper

Papers 3

  1. MGMT expression affects the gemcitabine resistance of pancreatic cancer cells. Co-author DOI 10.1016/j.lfs.2020.118148↗
  2. AUTS2 is a potential therapeutic target for pancreatic cancer patients with liver metastases. Co-author DOI 10.1016/j.mehy.2015.04.029↗
  3. SOCS3 methylation in synergy with Reg3A overexpression promotes cell growth in pancreatic cancer. Co-author DOI 10.1007/s00109-014-1184-8↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jianbo Ma · 1 shared paper, 2020 · strength 0.13
  2. Yu Shi · 1 shared paper, 2020 · strength 0.13
  3. Jing Qian · 1 shared paper, 2020 · strength 0.13
  4. Yan Wang · 1 shared paper, 2020 · strength 0.13
  5. Ying‐Yu Ma · 1 shared paper, 2015 · strength 0.05
  6. Hui‐Ju Wang · 1 shared paper, 2015 · strength 0.05
  7. Dong‐Sheng Huang · 1 shared paper, 2015 · strength 0.05
  8. Li Xu · 1 shared paper, 2014 · strength 0.04
  9. Xiulan Liu · 1 shared paper, 2014 · strength 0.04
  10. Ming Xiang · 1 shared paper, 2014 · strength 0.04
  11. Jun Wang · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.